Open Menu Close Menu
CFO
  • News
  • Resources
  • Webinars
  • CFO Magazine
  • Newsletter
Search

Roche

Roche Takes Full Control of Genomic Profiler

The $2.4 billion purchase of 44% of Foundation Medicine raises Roche's bet on the development of personalized cancer treatments and care.

Roche Buys Flatiron in $1.9B ‘Big Data’ Move

The real-world evidence Flatiron's record system collects "is a key ingredient to accelerate the development of, and access to, new cancer treatments."

Facebook CFO: “Wicked Smart,” But No Ego

David Ebersman is perfectly suited for the maelstrom to come when the social-media giant's IPO hits the market.

CFO Follow us on social media
LinkedIn Facebook Twitter YouTube

Topics

  • Accounting & Tax
  • Credit & Capital
  • Risk & Compliance
  • Strategy
  • Technology
  • Human Capital

Content

  • Homepage
  • News
  • Resources
  • Webinars
  • CFO Magazine

About CFO

  • About CFO
  • Privacy Policy
  • Editorial Staff
  • Press
  • Advertise
  • Contact Us

Stay Updated

Sign up to receive the CFO newsletter.

Copyright © 2021 CFO. Industry Dive, Inc. (c) 2021, All rights reserved, 1255 23rd Street, NW, Suite 550, Washington, DC 20037

We use cookies to optimize your experience on our website and for analytics and advertising purposes. By continuing to use our site, you agree to our cookie policy. Learn more